• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

神经外科肿瘤学中亚组分析的实践与统计学方面:来自先锋联盟的全面综述

Practical and statistical aspects of subgroup analyses in surgical neuro-oncology: A comprehensive review from the PIONEER consortium.

作者信息

Gerritsen Jasper K W, Karschnia Philipp, Young Jacob S, van den Bent Martin J, Chang Susan M, Smith Timothy R, Nahed Brian V, Rincon-Torroella Jordina, Bettegowda Chetan, Sanai Nader, Krieg Sandro M, Maruyama Takashi, Schucht Philippe, Broekman Marike L D, Tonn Joerg-Christian, Wen Patrick Y, De Vleeschouwer Steven, Vincent Arnaud J P E, Hervey-Jumper Shawn, Berger Mitchel S, Mekary Rania A, Molinaro Annette M

机构信息

Department of Neurosurgery, Erasmus Medical Center, Rotterdam, The Netherlands.

Department of Neurosurgery, University of California, San Francisco, California, USA.

出版信息

Neuro Oncol. 2025 Jun 21;27(5):1149-1164. doi: 10.1093/neuonc/noae261.

DOI:10.1093/neuonc/noae261
PMID:39657588
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12187369/
Abstract

Subgroup analyses are essential to generate new hypotheses or to estimate treatment effects in clinically meaningful subgroups of patients. They play an important role in taking the next step toward personalized surgical treatment for brain tumor patients. However, subgroup analyses must be used with consideration and care because they have significant potential risks. Although some recommendations are available on the pearls and pitfalls of these analyses, a comprehensive guide is lacking, especially one focused on surgical neuro-oncology patients. This paper, therefore, reviews and summarizes for the first time comprehensively the practical and statistical considerations that are critical to this field. First, we evaluate the considerations when choosing a study design for surgical neuro-oncology studies and examine those unique to this field. Second, we give an overview of the relevant aspects to interpret subgroup analyses adequately. Third, we discuss the practical and statistical elements necessary to appropriately design and use subgroup analyses. The paper aims to provide an in-depth and complete guide to better understand risk modeling and assist the reader with practical examples of designing, using, and interpreting subgroup analyses.

摘要

亚组分析对于生成新假设或估计临床意义上的患者亚组中的治疗效果至关重要。它们在迈向脑肿瘤患者个性化手术治疗的下一步中发挥着重要作用。然而,亚组分析必须谨慎使用,因为它们存在重大潜在风险。尽管对于这些分析的要点和陷阱有一些建议,但缺乏全面的指南,尤其是针对手术神经肿瘤学患者的指南。因此,本文首次全面回顾并总结了该领域至关重要的实践和统计学考量。首先,我们评估为手术神经肿瘤学研究选择研究设计时的考量,并审视该领域特有的考量。其次,我们概述充分解释亚组分析的相关方面。第三,我们讨论适当设计和使用亚组分析所需的实践和统计学要素。本文旨在提供一份深入且完整的指南,以更好地理解风险建模,并通过设计、使用和解释亚组分析的实际示例帮助读者。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3bfd/12187369/3f503b2fcdb7/noae261_fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3bfd/12187369/c75abf98e6c1/noae261_fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3bfd/12187369/a238c7962bfc/noae261_fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3bfd/12187369/f0b48cd1fca5/noae261_fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3bfd/12187369/3f503b2fcdb7/noae261_fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3bfd/12187369/c75abf98e6c1/noae261_fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3bfd/12187369/a238c7962bfc/noae261_fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3bfd/12187369/f0b48cd1fca5/noae261_fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3bfd/12187369/3f503b2fcdb7/noae261_fig4.jpg

相似文献

1
Practical and statistical aspects of subgroup analyses in surgical neuro-oncology: A comprehensive review from the PIONEER consortium.神经外科肿瘤学中亚组分析的实践与统计学方面:来自先锋联盟的全面综述
Neuro Oncol. 2025 Jun 21;27(5):1149-1164. doi: 10.1093/neuonc/noae261.
2
Assessing the comparative effects of interventions in COPD: a tutorial on network meta-analysis for clinicians.评估慢性阻塞性肺疾病干预措施的比较效果:面向临床医生的网状Meta分析教程
Respir Res. 2024 Dec 21;25(1):438. doi: 10.1186/s12931-024-03056-x.
3
Diagnostic test accuracy and cost-effectiveness of tests for codeletion of chromosomal arms 1p and 19q in people with glioma.染色体臂 1p 和 19q 缺失的检测在胶质瘤患者中的诊断准确性和成本效益。
Cochrane Database Syst Rev. 2022 Mar 2;3(3):CD013387. doi: 10.1002/14651858.CD013387.pub2.
4
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.利用预后信息为乳腺癌患者选择辅助性全身治疗的成本效益
Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340.
5
Eliciting adverse effects data from participants in clinical trials.从临床试验参与者中获取不良反应数据。
Cochrane Database Syst Rev. 2018 Jan 16;1(1):MR000039. doi: 10.1002/14651858.MR000039.pub2.
6
Carbamazepine versus phenytoin monotherapy for epilepsy: an individual participant data review.卡马西平与苯妥英钠单药治疗癫痫:个体参与者数据回顾
Cochrane Database Syst Rev. 2017 Feb 27;2(2):CD001911. doi: 10.1002/14651858.CD001911.pub3.
7
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.对紫杉醇、多西他赛、吉西他滨和长春瑞滨在非小细胞肺癌中的临床疗效和成本效益进行的快速系统评价。
Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320.
8
The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation.卡莫司汀植入剂与替莫唑胺治疗新诊断的高级别胶质瘤的有效性和成本效益:一项系统评价与经济学评估
Health Technol Assess. 2007 Nov;11(45):iii-iv, ix-221. doi: 10.3310/hta11450.
9
Home treatment for mental health problems: a systematic review.心理健康问题的居家治疗:一项系统综述
Health Technol Assess. 2001;5(15):1-139. doi: 10.3310/hta5150.
10
Behavioral interventions to reduce risk for sexual transmission of HIV among men who have sex with men.降低男男性行为者中艾滋病毒性传播风险的行为干预措施。
Cochrane Database Syst Rev. 2008 Jul 16(3):CD001230. doi: 10.1002/14651858.CD001230.pub2.

本文引用的文献

1
The oncological role of resection in newly diagnosed diffuse adult-type glioma defined by the WHO 2021 classification: a Review by the RANO resect group.世界卫生组织 2021 年分类定义的新诊断弥漫性成人型神经胶质瘤中切除术的肿瘤学作用: RANO 切除组的综述。
Lancet Oncol. 2024 Sep;25(9):e404-e419. doi: 10.1016/S1470-2045(24)00130-X.
2
SUPRAMAX-study: supramaximal resection versus maximal resection for glioblastoma patients: study protocol for an international multicentre prospective cohort study (ENCRAM 2201).SUPRAMAX 研究:最大程度切除与次最大程度切除治疗胶质母细胞瘤患者的效果比较:一项国际性多中心前瞻性队列研究方案(ENCRAM 2201)。
BMJ Open. 2024 Apr 29;14(4):e082274. doi: 10.1136/bmjopen-2023-082274.
3
Don't Be Blinded by the Blinding.
勿被致盲之物蒙蔽双眼。
NEJM Evid. 2022 Mar;1(3):EVIDe2100063. doi: 10.1056/EVIDe2100063. Epub 2022 Feb 22.
4
Adult neuro-oncology trials in the United States over 5 decades: Analysis of trials completion rate to guide the path forward.美国50多年来的成人神经肿瘤学试验:分析试验完成率以指导未来方向。
Neurooncol Adv. 2024 Jan 10;6(1):vdad169. doi: 10.1093/noajnl/vdad169. eCollection 2024 Jan-Dec.
5
Use of 5-ALA fluorescence-guided surgery versus white-light conventional microsurgery for the resection of newly diagnosed glioblastomas (RESECT study): a French multicenter randomized phase III study.5-ALA 荧光引导手术与白光常规显微镜手术在新诊断的胶质母细胞瘤切除中的应用(RESECT 研究):一项法国多中心随机 III 期研究。
J Neurosurg. 2023 Oct 13;140(4):987-1000. doi: 10.3171/2023.7.JNS231170. Print 2024 Apr 1.
6
Inaugural Results of the Individualized Screening Trial of Innovative Glioblastoma Therapy: A Phase II Platform Trial for Newly Diagnosed Glioblastoma Using Bayesian Adaptive Randomization.个体化新胶质母细胞瘤治疗筛查试验的初步结果:采用贝叶斯适应性随机化方法对新诊断胶质母细胞瘤进行的 II 期平台试验。
J Clin Oncol. 2023 Dec 20;41(36):5524-5535. doi: 10.1200/JCO.23.00493. Epub 2023 Sep 18.
7
Subgroup analyses in clinical research: too tempting?临床研究中的亚组分析:太诱人了?
Eur J Endocrinol. 2023 Aug 2;189(2):E1-E3. doi: 10.1093/ejendo/lvad089.
8
MR-guided LITT therapy in patients with primary irresectable glioblastoma: a prospective, controlled pilot study.磁共振引导下 LITT 治疗原发性不可切除胶质母细胞瘤患者:一项前瞻性、对照的初步研究。
J Neurooncol. 2023 Sep;164(2):405-412. doi: 10.1007/s11060-023-04371-x. Epub 2023 Jul 28.
9
Does waiting for surgery matter? How time from diagnostic MRI to resection affects outcomes in newly diagnosed glioblastoma.等待手术是否重要?新诊断的胶质母细胞瘤从诊断性 MRI 到切除的时间如何影响结果。
J Neurosurg. 2023 Jun 23;140(1):80-93. doi: 10.3171/2023.5.JNS23388. Print 2024 Jan 1.
10
Intraoperative MRI-Guided Resection Is Not Superior to 5-Aminolevulinic Acid Guidance in Newly Diagnosed Glioblastoma: A Prospective Controlled Multicenter Clinical Trial.术中磁共振引导切除并不优于 5-氨基酮戊酸引导在新诊断的胶质母细胞瘤:一项前瞻性对照多中心临床试验。
J Clin Oncol. 2023 Dec 20;41(36):5512-5523. doi: 10.1200/JCO.22.01862. Epub 2023 Jun 19.